HER2 and response to paclitaxel in node-positive breast cancer.
暂无分享,去创建一个
[1] Larry Norton,et al. HER2 and response to paclitaxel in node-positive breast cancer. , 2007, The New England journal of medicine.
[2] I. Ellis,et al. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Untch,et al. Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. , 2004, Journal of the National Cancer Institute.
[4] R. Gelber,et al. Predicting response to systemic treatments: learning from the past to plan for the future. , 2005, Breast.
[5] M. Dowsett,et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. , 2005, The New England journal of medicine.
[6] G. Abalı,et al. Which one is better: AIDS related or HIV associated? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. Berry,et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. , 2006, JAMA.
[8] M. Hung,et al. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A , 1997, Oncogene.
[9] Breast-Cancer Therapy — Looking Back to the Future , 2007 .
[10] R. Simon,et al. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. , 1978, The New England journal of medicine.
[11] Greg Yothers,et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.
[12] M. Cronin,et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.